Sort by
Refine Your Search
-
Listed
-
Program
-
Employer
-
Field
-
UiO/Anders Lien 10th April 2026 Languages English English English PhD Research Fellowship in Quantitative Imaging and Cell Mechanics of Early Embryo Development Apply for this job See advertisement
-
Quantitative Imaging and Cell Mechanics of Early Embryo Development Apply for this job See advertisement About the position A PhD fellowship is available at the Institute of Clinical Medicine, University of Oslo
-
Cellular and Molecular Neurobiology Apply for this job See advertisement About the position Position as PhD Research Fellow in Cellular and Molecular Neurobiology available at the Department of Biosciences
-
UiO/Anders Lien 8th March 2026 Languages English English English PhD Research Fellow in Cellular and Molecular Neurobiology Apply for this job See advertisement About the position Position as PhD
-
. candidate will use mammalian cells, organoids, and animal models, and employ a range of approaches, including cell culture systems, diverse molecular techniques, and advanced imaging. The project will involve
-
Mitophagy Regulators in Metabolic reprogramming during tumorigenesis (MiRMet)" in the Autophagy group which is also part of the Centre for Cancer Cell Reprogramming (CanCell). The primary objectives
-
between autophagy and metabolic rewiring in cancer (AutoWire)" in the Autophagy group which is also part of the Centre for Cancer Cell Reprogramming (CanCell). The AutoWire project is based on our recent
-
functions to work properly. Please turn on JavaScript in your browser and try again. UiO/Anders Lien 2nd January 2026 Languages English English English Researcher in Cancer Immunology and Cancer Cell Death
-
functions to work properly. Please turn on JavaScript in your browser and try again. Continuously Languages English English English Postdoctoral fellowship in in vitro human iPS cell-based neurodegenerative
-
programme Is the Job related to staff position within a Research Infrastructure? No Offer Description The project involves validation of new T-cell receptor-based immunotherapies in vitro for safety and